Trial Profile
Non-Interventional Trial About Treatment of Hemorrhages in Thyroid Surgery With TachoSil (TC-031-DE).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2014
Price :
$35
*
At a glance
- Drugs Fibrinogen/thrombin (Primary)
- Indications Haemorrhage
- Focus Therapeutic Use
- Sponsors Takeda Pharmaceuticals International GmbH
- 07 May 2012 Company added as trial association as reported by ClinicalTrials.gov.
- 16 Apr 2010 Planned end date changed from 1 Sep 2008 to 1 Jan 2009 as reported by ClinicalTrials.gov.
- 07 Apr 2010 Actual patient number (482) added as reported by ClinicalTrials.gov.